Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Whitt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Research|March 10, 2017
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletionJason D Whitt, Adam B Keeton, Bernard D Gary, et al.
Molecules (Basel, Switzerland)|October 29, 2020
Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor CellsZviadi Aburjania, Jason D Whitt, Samuel Jang, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
NSAIDs: Old Drugs Reveal New Anticancer TargetsGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Stem Cells International|December 10, 2015
Extracellular Vesicles: Evolving Factors in Stem Cell BiologyMuhammad Nawaz, Farah Fatima, Krishna C Vallabhaneni, et al.
Scientific Reports|March 23, 2025
Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancerShannon E Lynch, Corinne I Crawford, Hailey A Houson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2012
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activityJason D Whitt, Nan Li, Heather N Tinsley, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 28, 2009
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activityGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Cancers|February 11, 2023
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in RatsHeather N Tinsley, Bini Mathew, Xi Chen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Research|March 10, 2017
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletionJason D Whitt, Adam B Keeton, Bernard D Gary, et al.
Molecules (Basel, Switzerland)|October 29, 2020
Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor CellsZviadi Aburjania, Jason D Whitt, Samuel Jang, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
NSAIDs: Old Drugs Reveal New Anticancer TargetsGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Stem Cells International|December 10, 2015
Extracellular Vesicles: Evolving Factors in Stem Cell BiologyMuhammad Nawaz, Farah Fatima, Krishna C Vallabhaneni, et al.
Scientific Reports|March 23, 2025
Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancerShannon E Lynch, Corinne I Crawford, Hailey A Houson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2012
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activityJason D Whitt, Nan Li, Heather N Tinsley, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 28, 2009
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activityGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Cancers|February 11, 2023
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in RatsHeather N Tinsley, Bini Mathew, Xi Chen, et al.
Pageof 1